HIW
MTNB icon

Holos Integrated Wealth’s Matinas BioPharma MTNB Stock Holding History

Holos Integrated Wealth’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2K Hold
32,480
– – 0.01% 207
2026
Q1 		$16.3K Hold
32,480
– – 0.01% 223
2025
Q4 		$20.1K Hold
32,480
– – 0.01% 161
2025
Q3 		$55.5K Hold
32,480
– – 0.03% 113
2025
Q2 		$36.7K Hold
32,480
– – 0.02% 129
2025
Q1 		$16.9K Hold
32,480
– – 0.01% 166
2024
Q4 		$16.6K Buy
+32,480
New +$49.4K 0.01% 161

Other funds holding MTNB

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Holos Integrated Wealth's MTNB Position: Q2 2026 in Review

Holos Integrated Wealth held its Matinas BioPharma (MTNB) position steady in Q2 2026 at 32,480 shares worth $20.2K. The position accounts for 0.01% of the portfolio, ranked #207.

Holos Integrated Wealth first reported a position in MTNB in Q4 2024 and has held it in 7 quarters since. The position peaked at $55.5K in Q3 2025. 25 funds tracked by Wall St. Rank hold MTNB as of Q2 2026.

  • Holos Integrated Wealth held 32,480 shares of Matinas BioPharma worth $20.2K as of Q2 2026.
  • Holos Integrated Wealth left its Matinas BioPharma share count unchanged in Q2 2026.
  • Matinas BioPharma made up 0.01% of Holos Integrated Wealth's portfolio in Q2 2026, its #207 holding.
  • Holos Integrated Wealth first reported a position in Matinas BioPharma in Q4 2024 and has held it in 7 quarters since.
  • Holos Integrated Wealth's Matinas BioPharma position peaked at $55.5K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2026.

Based on Holos Integrated Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.